1.Clinical analysis of 901 cases with Henoch-Sch(o)nlein purpura in children
Ling LU ; Fang DENG ; Qin ZHANG ; Bo HU ; Ming GUI ; Liquan WU
Chinese Journal of Rheumatology 2008;12(6):407-409
Objective To investigate the variation of morbidity and clinical features of Henoch-Seh(o)nlein purpura (HSP) in childhood in recent years.Methods The clinical data of 901 cases with HSP admitted to our hospital from January 1,1995 to December 31,2005 were retrospectively analyzed.The constitute rate of admission,the initial clinical presentations,specific manifestations such as multi-system 23/2165(1.06%),29/2098(1.38%),24/1973(1.22%),39/2008(1.94%),54/2433(2.22%),86/2611(3.29%),94/2724(3.45%),99/3014(3;28%),138/2900(4.76%),143/3177(4.50%)and 172/3500(4.91%),resp-sixty-five of 901 HSP children (1 8.3%) had no palpable purpura at onset, 90 cases initially manifested as abdominal pain and (or) gastrointestinal bleeding,14 of them was diagnosed by gastroendoscopy which demonstrated mucous membrane vasculitis.Sixty-three cases manifested as arthritis/arthralgias,6 cases presented as renal involvement,1 case with neurological symptoms and 5 cases with other symptoms at their pancreatic involvement was present in 3 cases,cardiac involvement in 47 Cases and one case had lung hemorrhage.Conclusion The morbidity of HSP has increased in recent years.The diagnosis in patients who do not have palpable purpura at onset and patients who present with the cerebral,pulmonary,cardiac and pancreatic involvement as the initial manifestations is difficult.Special attention should be paid to this group of patients.Gastrointestinal endoscope is valuable in diagnosing HSP in patients whose initial symptoms are abdominal pain and (or) gastrointestinal bleeding.
2.Antibacterial activity of turmeric (Curcuma longa L ) extract and effect on bacterial cell membranes
Lu HAN ; Chao ZHOU ; Xiu-fang BI ; Mei-gui HUANG ; Gang HAO
Acta Pharmaceutica Sinica 2024;59(8):2265-2272
In the present study, the antibacterial spectrum of turmeric extract was analyzed by measuring the minimum inhibitory concentration (MIC), and the antibacterial mechanism of turmeric extract was elaborated by determining its effects on the permeability and integrity of the cytoplasmic membrane, energy metabolism, and the morphology of the tested bacteria (
3.Plasma level of myeloperoxidase is not elevated in patients with stable angina pectoris
Gui-Jing LU ; Wen-Long LIU ; Fang-Xiong LI ; Guo-Gang ZHANG ; Tian-Lun YANG ; BERGLUND L
Chinese Journal of Geriatrics 2003;0(11):-
Objective To investigate the plasma level change of myeloperoxidase(MPO)in patients suffering from stable angina pectoris.Methods Five hundred and seventy three patients underwent elective coronary angiography in a bi-racial cohort study,which included 295 patients with stable angina peetoris(SAP)and 278 subjects served as control.Plasma level of MPO and traditional risk factors of coronary artery disease(CAD)were measured.Results MPO levels did not differ significantly between control group and SAP group[126.3(95.8-160.2)mg/L vs 123.6(97.4-150.0) mg/L P>0.05].MPO levels were similar across ethnicity and gender[black male 119.6(94.8-146.9) mg/L,white male 124.6(99.9~154.6)mg/L,black female 124.0(93.3~152.3)mg/L and white female 127.5(95.3~159.8)mg/L],and were correlated positively with the levels ofⅦfactor(r= 0.251,P<0.01),fasting plasma glucose(r=0.095,P<0.05),triglyceride(r=0.186,P<0.01), total cholesterol(r=0.081,P<0.05),high-sensitivity C-reactive protein(r=0.123,P<0.01) and fibrinogen levels(r=0.077,P<0.01),negatively correlated with adiponectin level(r=-0.115, P<0.01).Conclusions Plasma MPO level is not elevated in patients with SAP.This suggests that MPO is not a characteristic feature of SAP.There are also no significant relationships between different genders and between different ethnicities.
4.Expression of transforming growth factor β1/Smad4 signal pathway in rats with nonalcoholic fatty liver disease
Hao PAN ; Aixia DOU ; Weihua CHEN ; Kun ZHOU ; Ting CHEN ; Changqing ZHU ; Xi GUI ; Jingyuan FANG ; Mingde ZENG ; Lungen LU
Chinese Journal of Digestion 2009;29(5):317-321
Objective To investigate the expression of transforming growth factor β1,transforming growth factor beta receptor(TBR)Ⅰ,TβR Ⅱ,Smad4 and C-Jun in rats with nonalcoholic fatty liver disease(NAFLD)and to find out the mechanisms of liver fibrosis in patients with NAFLD.Methods A total of 18 male SD rats were randomly divided into normal control group(n=9)and model group(n=9).The rats in control group were fed with normal diet,and those in model group were fed with fat-rich diet(consisted of 10%lard oil+2%cholesterol).An rats were sacrificed at the 20th week.The levels of TGFβ1,TβR Ⅰ and TβR Ⅱ mRNA were examined by RT-PCR.The expressions of TGFβ1 and Smad4 in liver tissue were detected by immunohistochemistry.The expression of C-Jun protein was detected by Western blotting.Results The NAFLD model was successfully established.The immunohistochemistry examination revealed that TGFβ1 and Smad4 were expressed weekly in control group,but strongly expressed in model group.RT-PCR showed that A values of TGFβ1,TβR Ⅰ and TβR Ⅱ mRNA were 0.46±0.12,5.z4±2.70 and 3.35±1.95,respectively,in model group,which were higher than those in control group(0.21±0.09,1.36±0.77 and 0.52±0.19,all P values<0.01).The Western blotting results demonstrated that the expression of C-Jun protein in model group(0.93±0.41)was higher than that in control group (0.32±0.25,P=0.001).Conclusion TGFβ1/Smad4 signal pathway might be involved in the development of hepatic fibrosis in NAFLD.Blocking TGFβ1/Smad4 signal pathway will be helpful in treatment of NAFLD.
5.Effect of ecoimmunonutrition supports on maintenance of integrity of intestinal mucosal barrier in severe acute pancreatitis in dogs.
Gui-fang XU ; Zheng LU ; Jun GAO ; Zhao-shen LI ; Yan-fang GONG
Chinese Medical Journal 2006;119(8):656-661
BACKGROUNDOne of the major causes of death in severe acute pancreatitis (SAP) is severe infection owing to bacterial translocation. Some clinical studies suggested that ecoimmunonutrition (EIN) as a new strategy had better treatment effect on SAP patients. But the experiment studies on the precise mechanism of the effect of EIN were less reported. In this study, we mainly investigated the effects of EIN on bacterial translocation in SAP model of dogs.
METHODSSAP was induced by retrograde infusion of 5% sodium taurocholate into the pancreatic duct in healthy hybrid dogs. The SAP dogs were supported with either parenteral nutrition (PN) or elemental enteral nutrition (EEN) or EIN. The levels of serum amylase, serum aminotransferase and plasma endotoxin were detected before and after pancreatitis induction. On the 7th day after nutrition supports, peritoneal fluid, mesenteric lymph nodes (MLN), liver, and pancreas were collected for bacterial culture with standard techniques to observe the incidence of bacterial translocation. Pathology changes of pancreas were analyzed by histopathologic grading and scoring of the severity of pancreas, and the degree of intestinal mucosal damage was assessed by measuring mucosal thickness, villus height, and crypt depth of ileum.
RESULTSCompared with PN and EEN, EIN significantly decreased the levels of serum amylase, serum aminotransferase, plasma endotoxin, and the incidence of bacterial translocation. Furthermore, compared with the others, the histology scores of inflammation in pancreas and the ileum injury (ileum mocosa thickness, villus height, and crypt depth) were significantly alleviated by EIN (P < 0.05). Moreover, concerning liver function, the serum levels of alanine aminotransferase, aspartate aminotransferase and albumin were ameliorating significantly in the EIN group.
CONCLUSIONOur results suggested that EIN could maintain the integrity of intestinal mucosal barrier and reducing the incidence of bacterial translocation in SAP dogs. Early EIN was safe and more effective treatment for SAP dogs.
Acute Disease ; Amylases ; metabolism ; Animals ; Bacteria ; isolation & purification ; Dogs ; Endotoxins ; blood ; Enteral Nutrition ; Immunity ; Intestinal Mucosa ; metabolism ; Liver ; physiopathology ; Nutritional Support ; Pancreas ; pathology ; Pancreatitis ; immunology ; metabolism ; therapy ; Parenteral Nutrition
6.Effects of arsenic trioxide combined with bortezomib on apoptosis of multiple myeloma cell line KM3 and its mechanisms.
Qun-Fang GE ; Gui-Fang OUYANG ; Ying CHEN ; Yi ZHANG ; Qi-Tian MU ; Ying LU
Journal of Experimental Hematology 2012;20(1):112-115
This study was purposed to investigate the effect of bortezomib (Bor) and arsenic trioxide (As(2)O(3)) combination on multiple myeloma cell line KM3 and its mechanisms. KM3 cells were cultured with different concentration of Bor or As(2)O(3) as well as both for a certain time. The cell proliferation was analysed by MTT assay and the concentration of 50% proliferation inhibition (IC(50)) was calculated. Early apoptosis and late apoptosis of KM3 cells were detected by Annexin-V-FITC Kit, and the change of transmembrane potential was measured by flow cytometry. mRNA of Caspase-3, Bim and Bcl-xL were detected by RT-PCR. The results showed that the proliferation inhibitory rate of KM3 cells treated by Bor plus As(2)O(3) was much higher than that of KM3 cells treated by Bor only for 72 h [ (27.64 ± 0.81)% vs (21.67 ± 2.20)%, P < 0.05]. There were more KM3 cells treated by Bor plus As(2)O(3) in early apoptosis at 48 h and late apoptosis at 72 h than that of KM3 cells treated only by Bor [ (53.20 ± 3.70)% vs (35.40 ± 2.58)%, P < 0.01; (63.96 ± 2.97)% vs (54.08 ± 3.76)%, P < 0.01]. Transmembrane potential (Δψm) of KM3 cells treated by Bor plus As(2)O(3) decreased more at 48 h, as compared with Bor alone. The expression levels of caspase-3 mRNA and Bim mRNA in KM3 cells treated with Bor plus As(2)O(3) were higher than that in KM3 cells treated with Bor alone. But the expression level of Bcl-xL mRNA was lower than that in KM3 cells treated with Bor alone. It is concluded that As(2)O(3) can enhance the apoptosis-inducing effect of Bor on multiple myeloma cell line KM3, which is associated with decreasing the expression of Bcl-xl mRNA and increasing the expression of Caspase-3 and Bim mRNA.
Apoptosis
;
drug effects
;
Apoptosis Regulatory Proteins
;
metabolism
;
Arsenicals
;
administration & dosage
;
pharmacology
;
Bcl-2-Like Protein 11
;
Boronic Acids
;
administration & dosage
;
pharmacology
;
Bortezomib
;
Caspase 3
;
metabolism
;
Cell Line, Tumor
;
Humans
;
Membrane Proteins
;
metabolism
;
Multiple Myeloma
;
metabolism
;
pathology
;
Oxides
;
administration & dosage
;
pharmacology
;
Proto-Oncogene Proteins
;
metabolism
;
Pyrazines
;
administration & dosage
;
pharmacology
;
bcl-X Protein
;
metabolism
7.Investigation the risk of two model virus in the laboratory
Yuan LI ; Guo-Yong MEI ; Hui-Ying JIANG ; Gui-Rong WANG ; Chan TIAN ; Lu HAN ; Wei-Fang HAN ; Qiang WEI ; Yong-Yun ZHOU ; Gui-Zhen WU ; Ke-Xia WANG ; Jun HAN
Chinese Journal of Experimental and Clinical Virology 2008;22(5):327-329
Objective To study the survival time of recombination rival in environment and inactivation ability of different disinfectant and ultraviolet radiation against virus. Methods NC membranes absorbed the recombinant adenovirus (rADV) or herpes simplex vires (rHSV) with green fluorescence protein (GFP) were laid, or immersed in various concentration of different disinfectants such as ethanol, sodium hypochlorite, lysol and geramine and then taked out them every 15 min, or exposed under ultraviolet radiation, then the NC membranes were adsorbed 1 h in cell, 37 ℃ 5 % CO248 h. The results were observed under the fluorescence microscope. Results (1) the average survival time of rHSV under environment is less than 60 min, rADV is almost up to 2 h. (2) The infection ability of rHSV and rADV was inactived 15 min by both ethanol(100%, 70% and 50%) and sodium hypochlorite (5%, 2.5% and 1.25%). (3) Two virus can be killed by 0.1% bromngeramine. (4) Both 5% and 2.5% lysol, but rADV can not lost the infection on Vero Cell until 75 min by 1.25% Lysol. (5) The rHSV was inactivated under ultraviolet radiation, but rADV was not. Conclusion The survival time of is different from beth envelope rival and the no-envelope viral under nature environment and the inactivate ability of disinfectant also is different between two model virus; Disinfectant should be choose according to virus type.
8.Study on the phenomenon of splashes and sprays from virology
Yuan LI ; Guo-Yong MEI ; Hui-Ying JIANG ; Gui-Rong WANG ; Qiang WEI ; Lu HAN ; Lei WANG ; Chan TIAN ; Wei-Fang HAN ; Gui-Zhen WU ; Ke-Xia WANG ; Jun HAN
Chinese Journal of Experimental and Clinical Virology 2009;23(6):458-460
Objective To investigate the phenomenon of accidental splashes and sprays from manipulation of recombinant virus material and to measure the approximate spilled distance when recombinant virus material inadveaenfly dropped in the biosafety laboratory.Methods first,two groups owning different experience simulated the course of accidental spills and splashes by recombinant adenovirus(rADV)which expressed green fluorescence protein(GFP),the GFP signal were observed in 96 well cell plate after spills appeared;Second,the routine two heishts(75 cm and 110 cm)and capacity(1 ml,1.5 ml,4 ml and 8 ml)of virus were chose to simulate the experiment of unexpected dropping.Results First,the positive quantity of the first group owning 5 years'experience is much less than the second group owning 2 years'work experience,the former was 7 positive wells,the latter was 81 positive when they used the pipette to operation.Second,when the unclosed test tubes(1 ml,1.5ml,4 ml and 8 ml recombinant virus)inadvertently dropped,the largest spill distance Was 0.92 m、1.57 m、2.63 mand 2.68 m respectively.Conclusion The better experience is important to make sure safety when we make infectious material;the contaminated distance increased with the amount of recombinant virus material.
9.Study on anti-HIV drugs in Egyptian medicinal plants.
Xiao-fang SUN ; Wei WANG ; Gui-you DU ; Wei-bo LU
China Journal of Chinese Materia Medica 2002;27(9):649-679
Antiviral Agents
;
isolation & purification
;
pharmacology
;
Croton
;
chemistry
;
Egypt
;
Gallic Acid
;
analogs & derivatives
;
chemistry
;
isolation & purification
;
pharmacology
;
Glucosides
;
chemistry
;
isolation & purification
;
pharmacology
;
HIV-1
;
drug effects
;
Molecular Structure
;
Phorbol Esters
;
chemistry
;
isolation & purification
;
pharmacology
;
Phyllanthus emblica
;
chemistry
;
Plant Extracts
;
pharmacology
;
Plants, Medicinal
;
chemistry
;
Virus Replication
;
drug effects
10.Immunotherapy of non-Hodgkin's lymphomas (NHL) by anti-CD22 antibody--review.
Ping-Ping LU ; Zhi-Yun MENG ; Ming-Xiao ZHOU ; Min-Wei WANG ; Gui-Fang DOU
Journal of Experimental Hematology 2006;14(6):1258-1261
CD22 is a transmembrane sialoglycoprotein and a member of the immunoglobulin superfamily. Its expression is restricted to the B cell lineage and a vast majority of B cell NHLs. CD22 plays a key role in B cell development, survival, and function. Humanized anti-CD22 antibodies were developed to minimize the immunogenicity and to enhance effector interactions during their developments of diagnostic and immunotherapeutic agent. Preclinical test with anti-CD22 antibodies indicates that a single, conjugated or radiolabeled agent has shown preliminary antitumor activity in patients with recurrent and heavily pretreated NHL. Anti-CD22 antibodies were well tolerated, without dose-dependant toxicity. Anti-CD22 antibodies are currently being evaluated in combination with rituximab, and the early results suggest that the combination of the two antibodies are well tolerated and may result in better clinical activity than the single agent alone. Thus, anti-CD22 antibodies are theoretically good candidates alone and in combination with other drugs in the treatment of B cell malignancies. In this review, the physiologic function and characteristics of CD22 antigen as target molecule of guide therapy for NHL, the types of anti-CD22 antibodies in therapy of NHL and the combination use with other antibodies were summarized.
Animals
;
Antibodies, Monoclonal
;
immunology
;
therapeutic use
;
Antibodies, Monoclonal, Humanized
;
Humans
;
Immunotherapy
;
Lymphoma, Non-Hodgkin
;
therapy
;
Sialic Acid Binding Ig-like Lectin 2
;
immunology